|
FY2025
12 months to Jun 30, 2025
|
FY2024
12 months to Jun 30, 2024
|
FY2023
12 months to Jun 30, 2023
|
FY2022
12 months to Jun 30, 2022
|
FY2020
12 months to Jun 30, 2020
|
|
|---|---|---|---|---|---|
| Net sales | |||||
| Cost of sales | |||||
| Gross profit | |||||
| Selling, general, and administrative expenses | |||||
| Operating loss | |||||
| Other (expense) income: | |||||
| Interest expense, net | |||||
| Intangible assets impairment | |||||
| Goodwill impairment | |||||
| Other income (expense), net | |||||
| Net other expense | |||||
| Loss before income taxes | |||||
| Income tax provision | |||||
| Net loss | |||||
| Deemed dividend on convertible preferred stock and accretion of discount | |||||
| Preferred stock dividend, in common stock, issued or to be issued | |||||
| Net loss attributable to common stockholders | |||||
| Net loss per common share: | |||||
| Net loss per common share basic | |||||
| Net loss per common share diluted | |||||
| Weighted average shares outstanding: | |||||
| Weighted average shares outstanding basic | |||||
| Weighted average shares outstanding diluted | |||||
Loading...